CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Elusys Therapeutics

For profitContributed to NMEWebsite ↗

Also known as: Elusys Therapeutics | Elusys Therapeutics, Inc. | ELUSYS THERAPEUTICS INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Feb 1, 2009

First marketed drug

Mar 18, 2016

First NDA

Mar 18, 2016

Last known activity

Dec 31, 2023

Acquired by Heat Biologics on Dec 21, 2021

Timeline

1990s

  1. Jan 1, 1998

    Elusys Therapeutics— Founded

2010s

  1. Mar 18, 2016

    obiltoxaximab— Marketing Organization

  2. Mar 18, 2016

    obiltoxaximab— NDA Organization

2020s

  1. Dec 21, 2021

    Heat Biologics— Acquired By

Drugs by trial phase (2 distinct, 7 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Recent trials (7)

Details

Founded
Pine Brook, NJ, US Jan 1, 1998
First NDA
Mar 18, 2016
Last known activity
Dec 31, 2023

Designations held

  • Orphan drug
  • Fast track